1. Home
  2. ISTR vs CUVL Comparison

ISTR vs CUVL Comparison

Compare ISTR & CUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Investar Holding Corporation

ISTR

Investar Holding Corporation

HOLD

Current Price

$31.09

Market Cap

415.1M

Sector

Finance

ML Signal

HOLD

Logo Clinuvel Pharmaceuticals Limited American Depositary Shares

CUVL

Clinuvel Pharmaceuticals Limited American Depositary Shares

N/A

Current Price

$6.34

Market Cap

374.2M

Sector

Miscellaneous

ML Signal

N/A

Company Overview

Basic Information
Metric
ISTR
CUVL
Founded
2006
N/A
Country
United States
Australia
Employees
N/A
16
Industry
Major Banks
Miscellaneous
Sector
Finance
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
415.1M
374.2M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
ISTR
CUVL
Price
$31.09
$6.34
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$31.50
N/A
AVG Volume (30 Days)
84.2K
13.8K
Earning Date
04-20-2026
N/A
Dividend Yield
1.59%
N/A
EPS Growth
4.41
N/A
EPS
1.38
N/A
Revenue
N/A
N/A
Revenue This Year
$66.56
N/A
Revenue Next Year
$5.18
N/A
P/E Ratio
$22.24
N/A
Revenue Growth
N/A
N/A
52 Week Low
$21.43
$5.95
52 Week High
$31.27
$8.20

Technical Indicators

Market Signals
Indicator
ISTR
CUVL
Relative Strength Index (RSI) 57.00 42.75
Support Level $28.75 $6.33
Resistance Level $31.27 $6.82
Average True Range (ATR) 0.54 0.43
MACD -0.02 -0.10
Stochastic Oscillator 70.00 18.89

Price Performance

Historical Comparison
ISTR
CUVL

About ISTR Investar Holding Corporation

Investar Holding Corp is a U.S.-based financial holding company. Through its subsidiaries, it offers a variety of commercial and retail lending products throughout its market areas, including business loans to small to medium-sized businesses, as well as loans to individuals. It has business operations spread across the United States and serves its customers through several service branches. The bank also offers cashier's checks, direct deposit of payroll and Social Security checks, night depository, bank-by-mail, automated teller machines with deposit automation, and debit cards.

About CUVL Clinuvel Pharmaceuticals Limited American Depositary Shares

Clinuvel distributes a single product, Scenesse, the only approved treatment for phototoxic reactions specifically associated with a rare genetic disease called erythropoietic protoporphyria. EPP causes extreme pain or burns from brief exposure to light, affecting a patient's quality of life. Scenesse is a patented dissolvable implant, comparable in size with a rice grain, injected underneath the skin roughly every three months for ongoing protection. The implant controls the release of a synthetic drug which promotes the production of more melanin, thereby reducing pain and increasing tolerance for light exposure. The majority of Clinuvel's earnings stem from Europe and the US.

Share on Social Networks: